Publications by authors named "H Nakabayashi"

Studies on targeted temperature management for postcardiac arrest syndrome have shown no difference in outcomes between normothermia and hypothermia in patients with postcardiac arrest brain injury. Therefore, further development of therapeutic methods for temperature control in cardiac arrest patients is desirable. Although animal studies have shown that inducing hypothermia during cardiac arrest improves outcomes, no clinically effective method has yet been reported.

View Article and Find Full Text PDF

We report a simple and efficient synthetic method for polydopamine (PDA)-coated solid silica nanoparticles (s-SiO@PDA NPs) encapsulating anionic near-infrared (NIR) fluorescent dyes through physical adsorption. Despite the use of anionic NIR fluorescent dyes indocyanine green (ICG) and 2-[2-[2-chloro-3-[2-[1,3-dihydro-3,3-dimethyl-1-(4-sulfobutyl)-2-indol-2-ylidene]-ethylidene]-1-cyclohexen-1-yl]-ethenyl]-3,3-dimethyl-1-(4-sulfobutyl)-3-indolium (IR-783), they were successfully immobilized on anionic s-SiO@PDA NP surfaces under acidic aqueous conditions. After embedding in the s-SiO@PDA NPs, the fluorescence of ICG was almost quenched, while a diminished IR-783 fluorescence remained observable.

View Article and Find Full Text PDF
Article Synopsis
  • Diabetic cardiomyopathy (DCM) mainly affects diastolic function and is linked to altered energy usage; PPARα is implicated in this condition and pemafibrate is a selective modulator that could have therapeutic effects.
  • In a study with 17 type 2 diabetes patients, pemafibrate was administered for 8-16 weeks, with echocardiography used to evaluate changes in diastolic function metrics like E/A ratio and e'.
  • Results showed that pemafibrate significantly improved diastolic function by increasing early diastolic annular velocities (e') and reducing the E/e' ratio, indicating its potential role in preventing DCM in diabetic patients.
View Article and Find Full Text PDF

As chimeric antigen receptor (CAR)-T cell therapy has been recently applied in clinics, controlling the fate of blood cells is increasingly important for curing blood disorders. In this study, we aim to construct proliferation-inducing and differentiation-inducing CARs (piCAR and diCAR) with two different antigen specificities and express them simultaneously on the cell surface. Since the two antigens are non-cross-reactive and exclusively activate piCAR or diCAR, sequential induction from cell proliferation to differentiation could be controlled by switching the antigens added in the culture medium.

View Article and Find Full Text PDF

Endoplasmic reticulum (ER) stress is a key pathogenic factor in type 1 and 2 diabetes. Glycogen synthase kinase 3 (Gsk-3) contributes to β-cell loss in mice. However, the mechanism by which Gsk-3 leads β-cell death remains unclear.

View Article and Find Full Text PDF